Intermediate Term Clinical Outcomes Using Donor Derived Cell-Free DNA Testing After Lung Transplantation
Purpose: Characterize the intermediate term clinical outcomes using donor derived cell-free DNA (ddcfDNA) testing and assess associations with donor specific antibody (DSA), culture (CX), acute cellular rejection (ACR), and chronic lung allograft dysfunction (CLAD), incidence after Lung Transplantation (LT).
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: , C.R. Ensor, A.M. Ramirez Source Type: research
More News: Bone Graft | Cardiology | Heart | Heart Transplant | Lung Transplant | Transplant Surgery | Transplants